Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-10-000027)

Filing Details

Accession Number:: 0000711377-10-000027
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-10-07 07:04:40
Reporting Period:: 2010-10-05

Filing Date:: 2010-10-07
Accepted Time:: 2010-10-07 07:04:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187556	M Lon Bohannon	Neogen Corp 620 Lesher Place Lansing MI 48912	President & Coo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-05	8,688	$13.55	359,730	No	4	M	Direct
Common Stock	Disposition	2010-10-05	8,688	$34.05	351,042	No	4	S	Direct
Common Stock	Acquisiton	2010-10-06	493	$13.55	351,535	No	4	M	Direct
Common Stock	Disposition	2010-10-06	493	$34.05	351,042	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Option (Right to buy)	Disposition	2010-10-05	8,688	$0.00	8,688	$13.55
Common Stock	Common Stock Option (Right to buy)	Disposition	2010-10-06	493	$0.00	493	$13.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,720		2012-08-09	No	4	M	Direct
60,277		2012-08-09	No	4	M	Direct

Footnotes

The options were granted 8/9/07 as NQ options and became exercisable 20% yearly thereafter.